Guy Ofir - Chief Financial Officer, Director at Raphael Pharmaceutical Inc.

Issuer-level insider activity

Role
Chief Financial Officer, Director
Issuer ticker
RAPH on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Guy Ofir since 03 Aug 2025

Reported holdings for Guy Ofir in Raphael Pharmaceutical Inc.

Form 4 holding Chief Financial Officer, Director

Raphael Pharmaceutical Inc.

Security class
Common Stock
Shares / value
1,266,455
Estimated value
$633,228
Report date
26 Jul 2022
Price
$0.5000
Ownership
Direct
Form 4 holding Chief Financial Officer, Director

Raphael Pharmaceutical Inc.

Security class
Warrants to Purchase Common Stock
Shares / value
1,000,000
Estimated value
Report date
05 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Guy Ofir in Raphael Pharmaceutical Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .